These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 20416531)

  • 1. Becton Dickinson Biosciences CAM5.2 does not stand for true CK8/18. Comment on "Peripheral ameloblastoma in-situ: an evidential fact of surface epithelium origin", Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108:763-7.
    Wu YL; Huang YF; Hsu JD; Han CP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May; 109(5):655-6; author reply 656-7. PubMed ID: 20416531
    [No Abstract]   [Full Text] [Related]  

  • 2. BD (Becton, Dickinson and Company) Biosciences manufactures anticytokeratin CAM5.2, not CK8/18 monoclonal antibody.
    Liao CL; Tzeng SL; Hsu JD; Chen PJ; Han CP
    Pathol Int; 2010 May; 60(5):417; author reply 418. PubMed ID: 20518894
    [No Abstract]   [Full Text] [Related]  

  • 3. CAM5.2 (Becton Dickinson Biosciences) is not synonymous with CK8/18 (Leica Microsystems).
    Wang KC; Hsu JD; Yao CC; Han CP
    Cytopathology; 2010 Aug; 21(4):277-8; author reply 278. PubMed ID: 20345964
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral ameloblastoma in-situ: an evidential fact of surface epithelium origin.
    Ide F; Mishima K; Miyazaki Y; Saito I; Kusama K
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov; 108(5):763-7. PubMed ID: 19748296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticytokeratin CAM5.2 is not synonymous with CK8/18 monoclonal antibody; and anticytokeratin CAM5.2 can be a marker for cytokeratin 8 but not for cytokeratin 18 and 19.
    Han CP; Hsu JD; Li YJ
    Am J Surg Pathol; 2010 Apr; 34(4):595; author reply 595-6, 596. PubMed ID: 20154593
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody to cytokeratin (CK8/CK18) is not derived from CAM5.2 clone, and anticytokeratin CAM5.2 (Becton Dickinson) is not synonymous with the antibody (CK8/CK18).
    Han CP; Hsu JD; Koo CL; Yang SF
    Hum Pathol; 2010 Apr; 41(4):616-7; author reply 617. PubMed ID: 20226963
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo cytokeratin patterns of expression in bioengineered human periodontal mucosa.
    Garzón I; Sánchez-Quevedo MC; Moreu G; González-Jaranay M; González-Andrades M; Montalvo A; Campos A; Alaminos M
    J Periodontal Res; 2009 Oct; 44(5):588-97. PubMed ID: 19438973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral ameloblastoma: report of case and review of the literature.
    Wesley RK; Borninski ER; Mintz S
    J Oral Surg; 1977 Aug; 35(8):670-2. PubMed ID: 267193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-cytokeratin CAM5.2 reagent (Becton Dickinson Biosciences) can detect CK 8, not CK8/18-Comment on "Sonographic findings in a patient with neurofibromatosis type 1 and a gastrointestinal stromal tumor," J Clin Ultrasound 2010 Jan 20 [Epub ahead of print].
    Chen PJ; Hsu JD; Han CP
    J Clin Ultrasound; 2010 Sep; 38(7):384; author reply 385. PubMed ID: 20623691
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunohistochemical studies of ameloblastoma with special emphasis on keratin.
    Ota Y; Goto J; Sasaki J; Osamura Y
    Tokai J Exp Clin Med; 1988 Dec; 13(4-5):219-26. PubMed ID: 2476873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Cytokeratin (CAM5.2) reagent directed against cytokeratin 8, not cytokeratin 18. Comment on "Improving staging accuracy in colon and rectal cancer by sentinel lymph node mapping: a comparative study. Eur J Surg Oncol. 2009; 35: 1065-1070.".
    Lin CK; Yao CC; Tseng SW; Han CP
    Eur J Surg Oncol; 2010 Apr; 36(4):428; author reply 429. PubMed ID: 20133104
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of molecules related to AKT pathway as putative regulators of ameloblastoma local invasiveness.
    Cecim RL; Carmo HA; Kataoka MS; Freitas VM; de Melo Alves Júnior S; Pedreira EN; Jaeger RG; Pinheiro JJ
    J Oral Pathol Med; 2014 Feb; 43(2):143-7. PubMed ID: 23837696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ameloblastoma of mucosal origin.
    Takeda Y; Kuroda M; Suzuki A
    Acta Pathol Jpn; 1988 Aug; 38(8):1053-60. PubMed ID: 3188913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral ameloblastoma with potentially malignant features: report of a case with special regard to its keratin profile.
    Tajima Y; Kuroda-Kawasaki M; Ohno J; Yi J; Kusama K; Tanaka H; Fukunaga S; Shimada J; Yamamoto Y
    J Oral Pathol Med; 2001 Sep; 30(8):494-8. PubMed ID: 11545241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAM5.2 is not identical to cytokeratins 8 and 18.
    Hsu JD; Yao CC; Han LW; Han CP
    Am J Clin Pathol; 2010 Mar; 133(3):514. PubMed ID: 20154291
    [No Abstract]   [Full Text] [Related]  

  • 16. The expression profiles of acidic epithelial keratins in ameloblastoma.
    Pal SK; Sakamoto K; Aragaki T; Akashi T; Yamaguchi A
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Apr; 115(4):523-31. PubMed ID: 23522646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunohistochemical study of two cases of either peripheral odontogenic fibroma (WHO type) or peripheral ameloblastoma.
    Chong Huat Siar ; Kok Han Ng
    J Nihon Univ Sch Dent; 1996 Mar; 38(1):52-6. PubMed ID: 8648412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A immunohistochemical study of the peripheral ameloblastoma.
    Kishino M; Murakami S; Yuki M; Iida S; Ogawa Y; Kogo M; Toyosawa S
    Oral Dis; 2007 Nov; 13(6):575-80. PubMed ID: 17944675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral ameloblastoma: review of the literature and report of recurrence as severe dysplasia.
    Wettan HL; Patella PA; Freedman PD
    J Oral Maxillofac Surg; 2001 Jul; 59(7):811-5. PubMed ID: 11429748
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-Cytokeratin CAM 5.2 (Becton Dickinson) is not synonymous with CK8/18 monoclonal antibody. Comment on "Pancreatic-type mixed acinar-endocrine carcinoma with alpha-fetoprotein production arising from the stomach: a report of an extremely rare case. Med Mol Morphol (2009) 42:167-174".
    Hsu JD; Han CP
    Med Mol Morphol; 2010 Mar; 43(1):65. PubMed ID: 20340009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.